UDK: 616.233-085.31

COMPARATIVE EFFICIENCY OF KORAKSAN (IVABRADIN) AND IZOPTIN SR (VERAPAMIL SR) IN CORONARY HEART DISEASE PATIENTS AGAINST A BACKGROUND OF BRONCHOOBSTRUCTIVE DISEASES

O. V. Magnitskaia, A. I. Malakhov, Yu. V. Lihodeeva, A. N. Podolskaia

Кафедра клинической фармакологии и интенсивной терапии с курсами клинической фармакологии ФУВ, клинической аллергологии ФУВ ВолГМУ

Abstract

Simple parallel group randomized investigation was performed. Ivabradin (or verapamil SR were administered for 4-week treatment of postMI silent ischemic patients with stable angina (class I-II) and concomitant controlled/partly controlled bronchial asthma or moderate/severe chronic obstructive pulmonary disease. Both drugs have demonstrated the same resting HR reduction, antianginal/antiischemic activity, tolerance of physical exertion improvement.

Keywords

coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), asthma, ivabradin, verapamil

Contacts

Магницкая Ольга Валерьевна — к. м. н., ассистент, докторант кафедры клинической фармакологии и интенсивной терапии с курсами клинической фармакологии ФУВ, клинической аллергологии ФУВ, e-mail: magol.73@mail.ru